nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—NR0B1—Dexamethasone—atopic dermatitis	0.123	0.19	CbGbCtD
Tretinoin—CYP2C18—Diphenhydramine—atopic dermatitis	0.075	0.116	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—atopic dermatitis	0.0591	0.0911	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.034	0.0525	CbGbCtD
Tretinoin—CYP3A7—Tacrolimus—atopic dermatitis	0.034	0.0525	CbGbCtD
Tretinoin—CYP2C8—Mometasone—atopic dermatitis	0.0313	0.0482	CbGbCtD
Tretinoin—CYP3A5—Tacrolimus—atopic dermatitis	0.0255	0.0393	CbGbCtD
Tretinoin—CYP2B6—Diphenhydramine—atopic dermatitis	0.0237	0.0366	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—atopic dermatitis	0.0214	0.033	CbGbCtD
Tretinoin—CYP2C8—Loratadine—atopic dermatitis	0.018	0.0277	CbGbCtD
Tretinoin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0167	0.0258	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0139	0.0214	CbGbCtD
Tretinoin—CYP3A7—Hydrocortisone—atopic dermatitis	0.0139	0.0214	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—atopic dermatitis	0.0126	0.0194	CbGbCtD
Tretinoin—CYP2C9—Loratadine—atopic dermatitis	0.0125	0.0193	CbGbCtD
Tretinoin—CYP2C9—Diphenhydramine—atopic dermatitis	0.0125	0.0193	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—atopic dermatitis	0.0108	0.0166	CbGbCtD
Tretinoin—CYP3A5—Hydrocortisone—atopic dermatitis	0.0104	0.016	CbGbCtD
Tretinoin—CYP2C8—Hydrocortisone—atopic dermatitis	0.00999	0.0154	CbGbCtD
Tretinoin—CYP3A4—Tacrolimus—atopic dermatitis	0.00995	0.0153	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00862	0.0133	CbGbCtD
Tretinoin—CYP3A7—Dexamethasone—atopic dermatitis	0.00862	0.0133	CbGbCtD
Tretinoin—CYP2B6—Dexamethasone—atopic dermatitis	0.0082	0.0126	CbGbCtD
Tretinoin—CYP3A4—Loratadine—atopic dermatitis	0.00728	0.0112	CbGbCtD
Tretinoin—CRABP2—skin epidermis—atopic dermatitis	0.00673	0.159	CbGeAlD
Tretinoin—CYP3A4—Methylprednisolone—atopic dermatitis	0.00666	0.0103	CbGbCtD
Tretinoin—CYP3A5—Dexamethasone—atopic dermatitis	0.00646	0.00996	CbGbCtD
Tretinoin—CYP2C8—Dexamethasone—atopic dermatitis	0.00621	0.00958	CbGbCtD
Tretinoin—CYP3A4—Triamcinolone—atopic dermatitis	0.00505	0.00778	CbGbCtD
Tretinoin—CYP2C9—Dexamethasone—atopic dermatitis	0.00433	0.00668	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—atopic dermatitis	0.00433	0.00668	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—atopic dermatitis	0.00427	0.00659	CbGbCtD
Tretinoin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00405	0.00625	CbGbCtD
Tretinoin—CYP3A4—Prednisone—atopic dermatitis	0.00404	0.00622	CbGbCtD
Tretinoin—CRABP1—neck—atopic dermatitis	0.00356	0.0842	CbGeAlD
Tretinoin—RARRES1—skin of body—atopic dermatitis	0.00312	0.0736	CbGeAlD
Tretinoin—RXRG—neck—atopic dermatitis	0.00282	0.0666	CbGeAlD
Tretinoin—ALDH1A1—neck—atopic dermatitis	0.00268	0.0635	CbGeAlD
Tretinoin—CYP3A4—Dexamethasone—atopic dermatitis	0.00252	0.00388	CbGbCtD
Tretinoin—CRABP1—skin of body—atopic dermatitis	0.00231	0.0545	CbGeAlD
Tretinoin—CRABP2—skin of body—atopic dermatitis	0.00209	0.0493	CbGeAlD
Tretinoin—ALDH1A1—skin of body—atopic dermatitis	0.00174	0.0411	CbGeAlD
Tretinoin—CYP1A1—skin epidermis—atopic dermatitis	0.00169	0.0399	CbGeAlD
Tretinoin—ALDH1A2—head—atopic dermatitis	0.00156	0.0369	CbGeAlD
Tretinoin—RARG—skin of body—atopic dermatitis	0.00152	0.036	CbGeAlD
Tretinoin—CRABP1—head—atopic dermatitis	0.0015	0.0356	CbGeAlD
Tretinoin—CRABP2—head—atopic dermatitis	0.00136	0.0322	CbGeAlD
Tretinoin—RXRA—head—atopic dermatitis	0.00135	0.032	CbGeAlD
Tretinoin—RARB—head—atopic dermatitis	0.00122	0.0288	CbGeAlD
Tretinoin—RXRG—head—atopic dermatitis	0.00119	0.0281	CbGeAlD
Tretinoin—ALDH1A1—head—atopic dermatitis	0.00113	0.0268	CbGeAlD
Tretinoin—RXRB—head—atopic dermatitis	0.00112	0.0264	CbGeAlD
Tretinoin—RARG—head—atopic dermatitis	0.000993	0.0235	CbGeAlD
Tretinoin—RARA—head—atopic dermatitis	0.000933	0.0221	CbGeAlD
Tretinoin—CYP1A1—skin of body—atopic dermatitis	0.000523	0.0124	CbGeAlD
Tretinoin—CYP2B6—skin of body—atopic dermatitis	0.000508	0.012	CbGeAlD
Tretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000483	0.0238	CbGpPWpGaD
Tretinoin—NR0B1—Nuclear Receptors—PPARA—atopic dermatitis	0.000443	0.0218	CbGpPWpGaD
Tretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000442	0.0217	CbGpPWpGaD
Tretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000433	0.0213	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000422	0.0208	CbGpPWpGaD
Tretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000416	0.0204	CbGpPWpGaD
Tretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000416	0.0204	CbGpPWpGaD
Tretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00039	0.0192	CbGpPWpGaD
Tretinoin—RARG—Nuclear Receptors—PPARA—atopic dermatitis	0.000357	0.0175	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00035	0.0172	CbGpPWpGaD
Tretinoin—NR0B1—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.00035	0.0172	CbGpPWpGaD
Tretinoin—CYP1A1—head—atopic dermatitis	0.000341	0.00807	CbGeAlD
Tretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000335	0.0165	CbGpPWpGaD
Tretinoin—CYP2B6—head—atopic dermatitis	0.000332	0.00784	CbGeAlD
Tretinoin—RXRG—Nuclear Receptors—PPARA—atopic dermatitis	0.000326	0.016	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptors—PPARA—atopic dermatitis	0.00032	0.0157	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000309	0.0152	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptors—PPARA—atopic dermatitis	0.000307	0.0151	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptors—PPARA—atopic dermatitis	0.000307	0.0151	CbGpPWpGaD
Tretinoin—RARG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000282	0.0139	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000279	0.0137	CbGpPWpGaD
Tretinoin—CYP4A11—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000273	0.0134	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—STAT6—atopic dermatitis	0.000268	0.0132	CbGpPWpGaD
Tretinoin—RXRG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000258	0.0127	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000253	0.0124	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—STAT6—atopic dermatitis	0.000252	0.0124	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000242	0.0119	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000242	0.0119	CbGpPWpGaD
Tretinoin—RARG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000239	0.0117	CbGpPWpGaD
Tretinoin—RXRA—REV-ERBA represses gene expression—PPARA—atopic dermatitis	0.000231	0.0113	CbGpPWpGaD
Tretinoin—RXRA—RORA activates circadian gene expression—PPARA—atopic dermatitis	0.000223	0.011	CbGpPWpGaD
Tretinoin—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00022	0.0108	CbGpPWpGaD
Tretinoin—RXRG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000219	0.0107	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000217	0.0106	CbGpPWpGaD
Tretinoin—RXRA—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000217	0.0106	CbGpPWpGaD
Tretinoin—RARB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000214	0.0105	CbGpPWpGaD
Tretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000212	0.0104	CbGpPWpGaD
Tretinoin—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000206	0.0101	CbGpPWpGaD
Tretinoin—RARA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000206	0.0101	CbGpPWpGaD
Tretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—PPARA—atopic dermatitis	0.000198	0.00975	CbGpPWpGaD
Tretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000194	0.00954	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000194	0.00953	CbGpPWpGaD
Tretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.00019	0.00935	CbGpPWpGaD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.00019	0.00932	CbGpPWpGaD
Tretinoin—CYP1A1—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000189	0.00927	CbGpPWpGaD
Tretinoin—NR0B1—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.000188	0.00925	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000187	0.00918	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000187	0.00918	CbGpPWpGaD
Tretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000182	0.00897	CbGpPWpGaD
Tretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000182	0.00897	CbGpPWpGaD
Tretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atopic dermatitis	0.000163	0.00803	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptors—PPARA—atopic dermatitis	0.00016	0.00786	CbGpPWpGaD
Tretinoin—RXRA—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	0.000153	0.00754	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	0.000153	0.00754	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000152	0.00748	CbGpPWpGaD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000152	0.00748	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional activation of mitochondrial biogenesis—PPARA—atopic dermatitis	0.00014	0.00686	CbGpPWpGaD
Tretinoin—RXRG—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.000139	0.00682	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—MAPK8—atopic dermatitis	0.000137	0.00675	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT6—atopic dermatitis	0.000131	0.00645	CbGpPWpGaD
Tretinoin—RXRB—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.00013	0.00641	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000126	0.00621	CbGpPWpGaD
Tretinoin—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	0.000122	0.00602	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—PPARA—atopic dermatitis	0.000122	0.00599	CbGpPWpGaD
Tretinoin—RXRA—Mitochondrial biogenesis—PPARA—atopic dermatitis	0.000121	0.00593	CbGpPWpGaD
Tretinoin—RXRA—Circadian Clock—PPARA—atopic dermatitis	0.000119	0.00585	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—PPARA—atopic dermatitis	0.000115	0.00564	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—atopic dermatitis	0.000109	0.00534	CbGpPWpGaD
Tretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000107	0.00527	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000106	0.00522	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000102	0.005	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	9.81e-05	0.00482	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	9.51e-05	0.00467	CbGpPWpGaD
Tretinoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.47e-05	0.00465	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	9.09e-05	0.00447	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	8.77e-05	0.00431	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—PPARA—atopic dermatitis	8.61e-05	0.00423	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	8.43e-05	0.00414	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GLB1—atopic dermatitis	8.31e-05	0.00409	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GLB1—atopic dermatitis	8.31e-05	0.00409	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GLB1—atopic dermatitis	8.31e-05	0.00409	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ADSL—atopic dermatitis	7.97e-05	0.00392	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ADSL—atopic dermatitis	7.97e-05	0.00392	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ADSL—atopic dermatitis	7.97e-05	0.00392	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	7.77e-05	0.00382	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	7.45e-05	0.00366	CbGpPWpGaD
Tretinoin—RXRA—Orphan transporters—PPARA—atopic dermatitis	7.14e-05	0.00351	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.13e-05	0.0035	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.01e-05	0.00345	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—PPARA—atopic dermatitis	6.83e-05	0.00336	CbGpPWpGaD
Tretinoin—RXRA—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	6.8e-05	0.00334	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	6.72e-05	0.0033	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	6.68e-05	0.00329	CbGpPWpGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.52e-05	0.00321	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.06e-05	0.00298	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.06e-05	0.00298	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—PPARA—atopic dermatitis	6.04e-05	0.00297	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—PPARA—atopic dermatitis	5.98e-05	0.00294	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	5.81e-05	0.00285	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.65e-05	0.00278	CbGpPWpGaD
Tretinoin—RXRA—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	5.48e-05	0.00269	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—TNF—atopic dermatitis	5.35e-05	0.00263	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.31e-05	0.00261	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—TNF—atopic dermatitis	5.03e-05	0.00247	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.88e-05	0.0024	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—PPARA—atopic dermatitis	4.87e-05	0.00239	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.68e-05	0.0023	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	4.66e-05	0.00229	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	4.61e-05	0.00226	CbGpPWpGaD
Tretinoin—Shock—Prednisolone—atopic dermatitis	4.54e-05	0.000157	CcSEcCtD
Tretinoin—Cough—Triamcinolone—atopic dermatitis	4.54e-05	0.000157	CcSEcCtD
Tretinoin—Headache—Tacrolimus—atopic dermatitis	4.53e-05	0.000157	CcSEcCtD
Tretinoin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.51e-05	0.000156	CcSEcCtD
Tretinoin—Oedema—Hydrocortisone—atopic dermatitis	4.51e-05	0.000156	CcSEcCtD
Tretinoin—Convulsion—Triamcinolone—atopic dermatitis	4.51e-05	0.000156	CcSEcCtD
Tretinoin—Tachycardia—Prednisolone—atopic dermatitis	4.51e-05	0.000156	CcSEcCtD
Tretinoin—Convulsion—Methylprednisolone—atopic dermatitis	4.5e-05	0.000156	CcSEcCtD
Tretinoin—Hypertension—Triamcinolone—atopic dermatitis	4.49e-05	0.000156	CcSEcCtD
Tretinoin—Hypertension—Methylprednisolone—atopic dermatitis	4.48e-05	0.000155	CcSEcCtD
Tretinoin—Infection—Hydrocortisone—atopic dermatitis	4.48e-05	0.000155	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisolone—atopic dermatitis	4.47e-05	0.000155	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—PPARA—atopic dermatitis	4.45e-05	0.00219	CbGpPWpGaD
Tretinoin—Shock—Hydrocortisone—atopic dermatitis	4.44e-05	0.000154	CcSEcCtD
Tretinoin—Myalgia—Triamcinolone—atopic dermatitis	4.43e-05	0.000154	CcSEcCtD
Tretinoin—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.42e-05	0.000153	CcSEcCtD
Tretinoin—Myalgia—Methylprednisolone—atopic dermatitis	4.42e-05	0.000153	CcSEcCtD
Tretinoin—Arthralgia—Methylprednisolone—atopic dermatitis	4.42e-05	0.000153	CcSEcCtD
Tretinoin—Eye disorder—Prednisone—atopic dermatitis	4.42e-05	0.000153	CcSEcCtD
Tretinoin—Anxiety—Methylprednisolone—atopic dermatitis	4.41e-05	0.000153	CcSEcCtD
Tretinoin—Tachycardia—Hydrocortisone—atopic dermatitis	4.4e-05	0.000153	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.39e-05	0.000152	CcSEcCtD
Tretinoin—Flushing—Prednisone—atopic dermatitis	4.38e-05	0.000152	CcSEcCtD
Tretinoin—Skin disorder—Hydrocortisone—atopic dermatitis	4.38e-05	0.000152	CcSEcCtD
Tretinoin—Ill-defined disorder—Betamethasone—atopic dermatitis	4.38e-05	0.000152	CcSEcCtD
Tretinoin—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.38e-05	0.000152	CcSEcCtD
Tretinoin—Discomfort—Triamcinolone—atopic dermatitis	4.38e-05	0.000152	CcSEcCtD
Tretinoin—Discomfort—Methylprednisolone—atopic dermatitis	4.37e-05	0.000151	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—PPARA—atopic dermatitis	4.37e-05	0.00215	CbGpPWpGaD
Tretinoin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.36e-05	0.000151	CcSEcCtD
Tretinoin—Dry mouth—Triamcinolone—atopic dermatitis	4.33e-05	0.00015	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—IL6—atopic dermatitis	4.32e-05	0.00212	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.3e-05	0.00211	CbGpPWpGaD
Tretinoin—Anorexia—Hydrocortisone—atopic dermatitis	4.3e-05	0.000149	CcSEcCtD
Tretinoin—Nausea—Tacrolimus—atopic dermatitis	4.3e-05	0.000149	CcSEcCtD
Tretinoin—Angiopathy—Prednisone—atopic dermatitis	4.29e-05	0.000149	CcSEcCtD
Tretinoin—Confusional state—Methylprednisolone—atopic dermatitis	4.27e-05	0.000148	CcSEcCtD
Tretinoin—Malaise—Dexamethasone—atopic dermatitis	4.26e-05	0.000148	CcSEcCtD
Tretinoin—Malaise—Betamethasone—atopic dermatitis	4.26e-05	0.000148	CcSEcCtD
Tretinoin—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.25e-05	0.000147	CcSEcCtD
Tretinoin—Oedema—Triamcinolone—atopic dermatitis	4.25e-05	0.000147	CcSEcCtD
Tretinoin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.24e-05	0.000147	CcSEcCtD
Tretinoin—Syncope—Betamethasone—atopic dermatitis	4.24e-05	0.000147	CcSEcCtD
Tretinoin—Syncope—Dexamethasone—atopic dermatitis	4.24e-05	0.000147	CcSEcCtD
Tretinoin—Arrhythmia—Prednisone—atopic dermatitis	4.22e-05	0.000146	CcSEcCtD
Tretinoin—Infection—Triamcinolone—atopic dermatitis	4.22e-05	0.000146	CcSEcCtD
Tretinoin—Hypotension—Hydrocortisone—atopic dermatitis	4.22e-05	0.000146	CcSEcCtD
Tretinoin—Infection—Methylprednisolone—atopic dermatitis	4.21e-05	0.000146	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—PPARA—atopic dermatitis	4.19e-05	0.00206	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARA—atopic dermatitis	4.19e-05	0.00206	CbGpPWpGaD
Tretinoin—Shock—Triamcinolone—atopic dermatitis	4.18e-05	0.000145	CcSEcCtD
Tretinoin—Insomnia—Prednisolone—atopic dermatitis	4.18e-05	0.000145	CcSEcCtD
Tretinoin—Alopecia—Prednisone—atopic dermatitis	4.18e-05	0.000145	CcSEcCtD
Tretinoin—Shock—Methylprednisolone—atopic dermatitis	4.17e-05	0.000144	CcSEcCtD
Tretinoin—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.16e-05	0.000144	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	4.15e-05	0.00204	CbGpPWpGaD
Tretinoin—Loss of consciousness—Betamethasone—atopic dermatitis	4.15e-05	0.000144	CcSEcCtD
Tretinoin—Loss of consciousness—Dexamethasone—atopic dermatitis	4.15e-05	0.000144	CcSEcCtD
Tretinoin—Paraesthesia—Prednisolone—atopic dermatitis	4.15e-05	0.000144	CcSEcCtD
Tretinoin—Tachycardia—Triamcinolone—atopic dermatitis	4.15e-05	0.000144	CcSEcCtD
Tretinoin—Mental disorder—Prednisone—atopic dermatitis	4.14e-05	0.000143	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	4.14e-05	0.00203	CbGpPWpGaD
Tretinoin—Tachycardia—Methylprednisolone—atopic dermatitis	4.14e-05	0.000143	CcSEcCtD
Tretinoin—Skin disorder—Methylprednisolone—atopic dermatitis	4.12e-05	0.000143	CcSEcCtD
Tretinoin—Erythema—Prednisone—atopic dermatitis	4.11e-05	0.000142	CcSEcCtD
Tretinoin—Malnutrition—Prednisone—atopic dermatitis	4.11e-05	0.000142	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.11e-05	0.000142	CcSEcCtD
Tretinoin—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.11e-05	0.000142	CcSEcCtD
Tretinoin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.1e-05	0.000142	CcSEcCtD
Tretinoin—Convulsion—Betamethasone—atopic dermatitis	4.09e-05	0.000142	CcSEcCtD
Tretinoin—Convulsion—Dexamethasone—atopic dermatitis	4.09e-05	0.000142	CcSEcCtD
Tretinoin—Insomnia—Hydrocortisone—atopic dermatitis	4.08e-05	0.000141	CcSEcCtD
Tretinoin—Hypertension—Dexamethasone—atopic dermatitis	4.08e-05	0.000141	CcSEcCtD
Tretinoin—Hypertension—Betamethasone—atopic dermatitis	4.08e-05	0.000141	CcSEcCtD
Tretinoin—RARA—Adipogenesis—IL6—atopic dermatitis	4.06e-05	0.002	CbGpPWpGaD
Tretinoin—Paraesthesia—Hydrocortisone—atopic dermatitis	4.05e-05	0.00014	CcSEcCtD
Tretinoin—Myalgia—Dexamethasone—atopic dermatitis	4.02e-05	0.000139	CcSEcCtD
Tretinoin—Myalgia—Betamethasone—atopic dermatitis	4.02e-05	0.000139	CcSEcCtD
Tretinoin—Anxiety—Dexamethasone—atopic dermatitis	4.01e-05	0.000139	CcSEcCtD
Tretinoin—Anxiety—Betamethasone—atopic dermatitis	4.01e-05	0.000139	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—atopic dermatitis	3.99e-05	0.00196	CbGpPWpGaD
Tretinoin—Discomfort—Betamethasone—atopic dermatitis	3.97e-05	0.000138	CcSEcCtD
Tretinoin—Discomfort—Dexamethasone—atopic dermatitis	3.97e-05	0.000138	CcSEcCtD
Tretinoin—Dyspepsia—Hydrocortisone—atopic dermatitis	3.97e-05	0.000138	CcSEcCtD
Tretinoin—Hypotension—Methylprednisolone—atopic dermatitis	3.96e-05	0.000137	CcSEcCtD
Tretinoin—Pain—Prednisolone—atopic dermatitis	3.95e-05	0.000137	CcSEcCtD
Tretinoin—Decreased appetite—Hydrocortisone—atopic dermatitis	3.92e-05	0.000136	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.89e-05	0.000135	CcSEcCtD
Tretinoin—Fatigue—Hydrocortisone—atopic dermatitis	3.89e-05	0.000135	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.88e-05	0.00191	CbGpPWpGaD
Tretinoin—Vision blurred—Prednisone—atopic dermatitis	3.88e-05	0.000134	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.87e-05	0.000134	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.86e-05	0.000134	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.86e-05	0.0019	CbGpPWpGaD
Tretinoin—Pain—Hydrocortisone—atopic dermatitis	3.86e-05	0.000134	CcSEcCtD
Tretinoin—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.85e-05	0.000134	CcSEcCtD
Tretinoin—Anaphylactic shock—Betamethasone—atopic dermatitis	3.85e-05	0.000134	CcSEcCtD
Tretinoin—Oedema—Dexamethasone—atopic dermatitis	3.85e-05	0.000134	CcSEcCtD
Tretinoin—Oedema—Betamethasone—atopic dermatitis	3.85e-05	0.000134	CcSEcCtD
Tretinoin—Insomnia—Triamcinolone—atopic dermatitis	3.84e-05	0.000133	CcSEcCtD
Tretinoin—Insomnia—Methylprednisolone—atopic dermatitis	3.83e-05	0.000133	CcSEcCtD
Tretinoin—Infection—Betamethasone—atopic dermatitis	3.83e-05	0.000133	CcSEcCtD
Tretinoin—Infection—Dexamethasone—atopic dermatitis	3.83e-05	0.000133	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—atopic dermatitis	3.82e-05	0.000132	CcSEcCtD
Tretinoin—Paraesthesia—Triamcinolone—atopic dermatitis	3.81e-05	0.000132	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—atopic dermatitis	3.81e-05	0.000132	CcSEcCtD
Tretinoin—Paraesthesia—Methylprednisolone—atopic dermatitis	3.81e-05	0.000132	CcSEcCtD
Tretinoin—Anaemia—Prednisone—atopic dermatitis	3.8e-05	0.000132	CcSEcCtD
Tretinoin—Shock—Betamethasone—atopic dermatitis	3.79e-05	0.000131	CcSEcCtD
Tretinoin—Shock—Dexamethasone—atopic dermatitis	3.79e-05	0.000131	CcSEcCtD
Tretinoin—Dyspnoea—Triamcinolone—atopic dermatitis	3.79e-05	0.000131	CcSEcCtD
Tretinoin—Nervous system disorder—Betamethasone—atopic dermatitis	3.78e-05	0.000131	CcSEcCtD
Tretinoin—Nervous system disorder—Dexamethasone—atopic dermatitis	3.78e-05	0.000131	CcSEcCtD
Tretinoin—Agitation—Prednisone—atopic dermatitis	3.78e-05	0.000131	CcSEcCtD
Tretinoin—Thrombocytopenia—Betamethasone—atopic dermatitis	3.77e-05	0.000131	CcSEcCtD
Tretinoin—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.77e-05	0.000131	CcSEcCtD
Tretinoin—Tachycardia—Dexamethasone—atopic dermatitis	3.76e-05	0.00013	CcSEcCtD
Tretinoin—Tachycardia—Betamethasone—atopic dermatitis	3.76e-05	0.00013	CcSEcCtD
Tretinoin—Dyspepsia—Triamcinolone—atopic dermatitis	3.74e-05	0.00013	CcSEcCtD
Tretinoin—Dyspepsia—Methylprednisolone—atopic dermatitis	3.73e-05	0.000129	CcSEcCtD
Tretinoin—Hyperhidrosis—Betamethasone—atopic dermatitis	3.73e-05	0.000129	CcSEcCtD
Tretinoin—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.73e-05	0.000129	CcSEcCtD
Tretinoin—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.72e-05	0.000129	CcSEcCtD
Tretinoin—Malaise—Prednisone—atopic dermatitis	3.71e-05	0.000128	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.7e-05	0.00182	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.69e-05	0.000128	CcSEcCtD
Tretinoin—Syncope—Prednisone—atopic dermatitis	3.69e-05	0.000128	CcSEcCtD
Tretinoin—Anorexia—Betamethasone—atopic dermatitis	3.67e-05	0.000127	CcSEcCtD
Tretinoin—Anorexia—Dexamethasone—atopic dermatitis	3.67e-05	0.000127	CcSEcCtD
Tretinoin—Urticaria—Prednisolone—atopic dermatitis	3.67e-05	0.000127	CcSEcCtD
Tretinoin—Fatigue—Triamcinolone—atopic dermatitis	3.66e-05	0.000127	CcSEcCtD
Tretinoin—Fatigue—Methylprednisolone—atopic dermatitis	3.65e-05	0.000127	CcSEcCtD
Tretinoin—Pain—Triamcinolone—atopic dermatitis	3.63e-05	0.000126	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—atopic dermatitis	3.61e-05	0.000125	CcSEcCtD
Tretinoin—Hypotension—Betamethasone—atopic dermatitis	3.6e-05	0.000125	CcSEcCtD
Tretinoin—Hypotension—Dexamethasone—atopic dermatitis	3.6e-05	0.000125	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.6e-05	0.00177	CbGpPWpGaD
Tretinoin—Urticaria—Hydrocortisone—atopic dermatitis	3.58e-05	0.000124	CcSEcCtD
Tretinoin—Abdominal pain—Hydrocortisone—atopic dermatitis	3.57e-05	0.000124	CcSEcCtD
Tretinoin—Body temperature increased—Hydrocortisone—atopic dermatitis	3.57e-05	0.000124	CcSEcCtD
Tretinoin—Convulsion—Prednisone—atopic dermatitis	3.56e-05	0.000123	CcSEcCtD
Tretinoin—Hypertension—Prednisone—atopic dermatitis	3.55e-05	0.000123	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.51e-05	0.000122	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.51e-05	0.000122	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.5e-05	0.00172	CbGpPWpGaD
Tretinoin—Arthralgia—Prednisone—atopic dermatitis	3.5e-05	0.000121	CcSEcCtD
Tretinoin—Myalgia—Prednisone—atopic dermatitis	3.5e-05	0.000121	CcSEcCtD
Tretinoin—Feeling abnormal—Triamcinolone—atopic dermatitis	3.5e-05	0.000121	CcSEcCtD
Tretinoin—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.49e-05	0.000121	CcSEcCtD
Tretinoin—Anxiety—Prednisone—atopic dermatitis	3.49e-05	0.000121	CcSEcCtD
Tretinoin—Insomnia—Betamethasone—atopic dermatitis	3.49e-05	0.000121	CcSEcCtD
Tretinoin—Insomnia—Dexamethasone—atopic dermatitis	3.49e-05	0.000121	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.48e-05	0.00012	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.47e-05	0.00012	CcSEcCtD
Tretinoin—Paraesthesia—Betamethasone—atopic dermatitis	3.46e-05	0.00012	CcSEcCtD
Tretinoin—Paraesthesia—Dexamethasone—atopic dermatitis	3.46e-05	0.00012	CcSEcCtD
Tretinoin—Discomfort—Prednisone—atopic dermatitis	3.46e-05	0.00012	CcSEcCtD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	3.42e-05	0.00168	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisolone—atopic dermatitis	3.4e-05	0.000118	CcSEcCtD
Tretinoin—Dyspepsia—Dexamethasone—atopic dermatitis	3.39e-05	0.000118	CcSEcCtD
Tretinoin—Dyspepsia—Betamethasone—atopic dermatitis	3.39e-05	0.000118	CcSEcCtD
Tretinoin—Urticaria—Triamcinolone—atopic dermatitis	3.37e-05	0.000117	CcSEcCtD
Tretinoin—Urticaria—Methylprednisolone—atopic dermatitis	3.37e-05	0.000117	CcSEcCtD
Tretinoin—Body temperature increased—Triamcinolone—atopic dermatitis	3.36e-05	0.000116	CcSEcCtD
Tretinoin—Oedema—Prednisone—atopic dermatitis	3.36e-05	0.000116	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—atopic dermatitis	3.36e-05	0.000116	CcSEcCtD
Tretinoin—Abdominal pain—Methylprednisolone—atopic dermatitis	3.35e-05	0.000116	CcSEcCtD
Tretinoin—Decreased appetite—Betamethasone—atopic dermatitis	3.35e-05	0.000116	CcSEcCtD
Tretinoin—Decreased appetite—Dexamethasone—atopic dermatitis	3.35e-05	0.000116	CcSEcCtD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	3.34e-05	0.00164	CbGpPWpGaD
Tretinoin—Infection—Prednisone—atopic dermatitis	3.33e-05	0.000116	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.33e-05	0.000115	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.33e-05	0.000115	CcSEcCtD
Tretinoin—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.32e-05	0.000115	CcSEcCtD
Tretinoin—Fatigue—Betamethasone—atopic dermatitis	3.32e-05	0.000115	CcSEcCtD
Tretinoin—Fatigue—Dexamethasone—atopic dermatitis	3.32e-05	0.000115	CcSEcCtD
Tretinoin—Shock—Prednisone—atopic dermatitis	3.3e-05	0.000114	CcSEcCtD
Tretinoin—Pain—Dexamethasone—atopic dermatitis	3.3e-05	0.000114	CcSEcCtD
Tretinoin—Pain—Betamethasone—atopic dermatitis	3.3e-05	0.000114	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—atopic dermatitis	3.29e-05	0.000114	CcSEcCtD
Tretinoin—Tachycardia—Prednisone—atopic dermatitis	3.28e-05	0.000113	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—atopic dermatitis	3.26e-05	0.000113	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—atopic dermatitis	3.25e-05	0.000112	CcSEcCtD
Tretinoin—Asthenia—Hydrocortisone—atopic dermatitis	3.24e-05	0.000112	CcSEcCtD
Tretinoin—Anorexia—Prednisone—atopic dermatitis	3.2e-05	0.000111	CcSEcCtD
Tretinoin—Pruritus—Hydrocortisone—atopic dermatitis	3.19e-05	0.000111	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—atopic dermatitis	3.18e-05	0.00011	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—atopic dermatitis	3.18e-05	0.00011	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—GLB1—atopic dermatitis	3.17e-05	0.00156	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.15e-05	0.000109	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.15e-05	0.000109	CcSEcCtD
Tretinoin—Hypersensitivity—Triamcinolone—atopic dermatitis	3.13e-05	0.000108	CcSEcCtD
Tretinoin—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.12e-05	0.000108	CcSEcCtD
Tretinoin—Diarrhoea—Hydrocortisone—atopic dermatitis	3.09e-05	0.000107	CcSEcCtD
Tretinoin—Urticaria—Betamethasone—atopic dermatitis	3.06e-05	0.000106	CcSEcCtD
Tretinoin—Urticaria—Dexamethasone—atopic dermatitis	3.06e-05	0.000106	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.06e-05	0.000106	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—Asthenia—Triamcinolone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—atopic dermatitis	3.05e-05	0.000106	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—ADSL—atopic dermatitis	3.04e-05	0.0015	CbGpPWpGaD
Tretinoin—Asthenia—Methylprednisolone—atopic dermatitis	3.04e-05	0.000105	CcSEcCtD
Tretinoin—Insomnia—Prednisone—atopic dermatitis	3.04e-05	0.000105	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—atopic dermatitis	3.01e-05	0.000104	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	3.01e-05	0.00148	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	3.01e-05	0.00148	CbGpPWpGaD
Tretinoin—Pruritus—Triamcinolone—atopic dermatitis	3.01e-05	0.000104	CcSEcCtD
Tretinoin—Pruritus—Methylprednisolone—atopic dermatitis	3e-05	0.000104	CcSEcCtD
Tretinoin—Dizziness—Hydrocortisone—atopic dermatitis	2.98e-05	0.000103	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—atopic dermatitis	2.95e-05	0.000102	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—atopic dermatitis	2.92e-05	0.000101	CcSEcCtD
Tretinoin—Rash—Prednisolone—atopic dermatitis	2.91e-05	0.000101	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—atopic dermatitis	2.91e-05	0.000101	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—PPARA—atopic dermatitis	2.91e-05	0.00143	CbGpPWpGaD
Tretinoin—Diarrhoea—Methylprednisolone—atopic dermatitis	2.9e-05	0.0001	CcSEcCtD
Tretinoin—Fatigue—Prednisone—atopic dermatitis	2.89e-05	0.0001	CcSEcCtD
Tretinoin—Headache—Prednisolone—atopic dermatitis	2.89e-05	0.0001	CcSEcCtD
Tretinoin—Constipation—Prednisone—atopic dermatitis	2.87e-05	9.94e-05	CcSEcCtD
Tretinoin—Vomiting—Hydrocortisone—atopic dermatitis	2.87e-05	9.94e-05	CcSEcCtD
Tretinoin—Rash—Hydrocortisone—atopic dermatitis	2.84e-05	9.85e-05	CcSEcCtD
Tretinoin—Dermatitis—Hydrocortisone—atopic dermatitis	2.84e-05	9.85e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.83e-05	0.00139	CbGpPWpGaD
Tretinoin—Headache—Hydrocortisone—atopic dermatitis	2.83e-05	9.79e-05	CcSEcCtD
Tretinoin—Dizziness—Triamcinolone—atopic dermatitis	2.81e-05	9.73e-05	CcSEcCtD
Tretinoin—Dizziness—Methylprednisolone—atopic dermatitis	2.8e-05	9.71e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—GLB1—atopic dermatitis	2.77e-05	0.00136	CbGpPWpGaD
Tretinoin—Feeling abnormal—Prednisone—atopic dermatitis	2.77e-05	9.58e-05	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—atopic dermatitis	2.77e-05	9.58e-05	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—atopic dermatitis	2.77e-05	9.58e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—atopic dermatitis	2.74e-05	9.51e-05	CcSEcCtD
Tretinoin—Nausea—Prednisolone—atopic dermatitis	2.74e-05	9.51e-05	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—atopic dermatitis	2.73e-05	9.45e-05	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—atopic dermatitis	2.73e-05	9.45e-05	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—atopic dermatitis	2.7e-05	9.36e-05	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—PPARA—atopic dermatitis	2.7e-05	0.00133	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARA—atopic dermatitis	2.7e-05	0.00133	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARA—atopic dermatitis	2.7e-05	0.00133	CbGpPWpGaD
Tretinoin—Vomiting—Methylprednisolone—atopic dermatitis	2.69e-05	9.34e-05	CcSEcCtD
Tretinoin—Nausea—Hydrocortisone—atopic dermatitis	2.68e-05	9.28e-05	CcSEcCtD
Tretinoin—Rash—Triamcinolone—atopic dermatitis	2.68e-05	9.28e-05	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—atopic dermatitis	2.68e-05	9.27e-05	CcSEcCtD
Tretinoin—Rash—Methylprednisolone—atopic dermatitis	2.67e-05	9.26e-05	CcSEcCtD
Tretinoin—Dermatitis—Methylprednisolone—atopic dermatitis	2.67e-05	9.25e-05	CcSEcCtD
Tretinoin—Urticaria—Prednisone—atopic dermatitis	2.67e-05	9.24e-05	CcSEcCtD
Tretinoin—Headache—Triamcinolone—atopic dermatitis	2.66e-05	9.22e-05	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—ADSL—atopic dermatitis	2.66e-05	0.00131	CbGpPWpGaD
Tretinoin—Headache—Methylprednisolone—atopic dermatitis	2.66e-05	9.2e-05	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—atopic dermatitis	2.65e-05	9.19e-05	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—atopic dermatitis	2.65e-05	9.19e-05	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—atopic dermatitis	2.64e-05	9.14e-05	CcSEcCtD
Tretinoin—Diarrhoea—Betamethasone—atopic dermatitis	2.64e-05	9.14e-05	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—TNF—atopic dermatitis	2.62e-05	0.00129	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.59e-05	0.00127	CbGpPWpGaD
Tretinoin—Dizziness—Betamethasone—atopic dermatitis	2.55e-05	8.83e-05	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—atopic dermatitis	2.55e-05	8.83e-05	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—atopic dermatitis	2.52e-05	8.74e-05	CcSEcCtD
Tretinoin—Nausea—Methylprednisolone—atopic dermatitis	2.52e-05	8.72e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—GLB1—atopic dermatitis	2.52e-05	0.00124	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisone—atopic dermatitis	2.47e-05	8.57e-05	CcSEcCtD
Tretinoin—Vomiting—Betamethasone—atopic dermatitis	2.45e-05	8.49e-05	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—atopic dermatitis	2.45e-05	8.49e-05	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.44e-05	0.0012	CbGpPWpGaD
Tretinoin—Rash—Dexamethasone—atopic dermatitis	2.43e-05	8.42e-05	CcSEcCtD
Tretinoin—Rash—Betamethasone—atopic dermatitis	2.43e-05	8.42e-05	CcSEcCtD
Tretinoin—Dermatitis—Dexamethasone—atopic dermatitis	2.43e-05	8.41e-05	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—atopic dermatitis	2.43e-05	8.41e-05	CcSEcCtD
Tretinoin—Headache—Dexamethasone—atopic dermatitis	2.41e-05	8.37e-05	CcSEcCtD
Tretinoin—Headache—Betamethasone—atopic dermatitis	2.41e-05	8.37e-05	CcSEcCtD
Tretinoin—RXRA—Metabolism—ADSL—atopic dermatitis	2.41e-05	0.00119	CbGpPWpGaD
Tretinoin—Asthenia—Prednisone—atopic dermatitis	2.41e-05	8.34e-05	CcSEcCtD
Tretinoin—Pruritus—Prednisone—atopic dermatitis	2.37e-05	8.23e-05	CcSEcCtD
Tretinoin—RARG—Gene Expression—PPARA—atopic dermatitis	2.34e-05	0.00115	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.31e-05	0.00114	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	2.3e-05	0.00113	CbGpPWpGaD
Tretinoin—Diarrhoea—Prednisone—atopic dermatitis	2.3e-05	7.96e-05	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—atopic dermatitis	2.29e-05	7.93e-05	CcSEcCtD
Tretinoin—Nausea—Betamethasone—atopic dermatitis	2.29e-05	7.93e-05	CcSEcCtD
Tretinoin—Dizziness—Prednisone—atopic dermatitis	2.22e-05	7.69e-05	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—PPARA—atopic dermatitis	2.18e-05	0.00107	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—PPARA—atopic dermatitis	2.14e-05	0.00105	CbGpPWpGaD
Tretinoin—Vomiting—Prednisone—atopic dermatitis	2.13e-05	7.39e-05	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—IL6—atopic dermatitis	2.12e-05	0.00104	CbGpPWpGaD
Tretinoin—Rash—Prednisone—atopic dermatitis	2.12e-05	7.33e-05	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—atopic dermatitis	2.11e-05	7.33e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.11e-05	0.00104	CbGpPWpGaD
Tretinoin—Headache—Prednisone—atopic dermatitis	2.1e-05	7.29e-05	CcSEcCtD
Tretinoin—RARB—Gene Expression—PPARA—atopic dermatitis	2.1e-05	0.00103	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARA—atopic dermatitis	2.05e-05	0.00101	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARA—atopic dermatitis	2.02e-05	0.000991	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARA—atopic dermatitis	2.02e-05	0.000991	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—atopic dermatitis	1.99e-05	6.91e-05	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.93e-05	0.000948	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.84e-05	0.000906	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.83e-05	0.000902	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.77e-05	0.000869	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.74e-05	0.000857	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GLB1—atopic dermatitis	1.69e-05	0.000831	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ADSL—atopic dermatitis	1.62e-05	0.000797	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GLB1—atopic dermatitis	1.36e-05	0.00067	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.33e-05	0.000655	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ADSL—atopic dermatitis	1.31e-05	0.000643	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.28e-05	0.000628	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GLB1—atopic dermatitis	1.26e-05	0.000619	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADSL—atopic dermatitis	1.21e-05	0.000593	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GLB1—atopic dermatitis	1.15e-05	0.000568	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADSL—atopic dermatitis	1.11e-05	0.000544	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARA—atopic dermatitis	1.05e-05	0.000516	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARA—atopic dermatitis	1.03e-05	0.000506	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GLB1—atopic dermatitis	9.4e-06	0.000462	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.18e-06	0.000451	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—atopic dermatitis	9.02e-06	0.000443	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADSL—atopic dermatitis	9.01e-06	0.000443	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARA—atopic dermatitis	9e-06	0.000442	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.41e-06	0.000414	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARA—atopic dermatitis	8.17e-06	0.000402	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—atopic dermatitis	7.28e-06	0.000358	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.85e-06	0.000337	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.2e-06	0.000305	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARA—atopic dermatitis	5.98e-06	0.000294	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.94e-06	0.000292	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARA—atopic dermatitis	5.49e-06	0.00027	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARA—atopic dermatitis	4.43e-06	0.000218	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.33e-06	0.000213	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARA—atopic dermatitis	4.09e-06	0.000201	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARA—atopic dermatitis	3.75e-06	0.000184	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.05e-06	0.00015	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.01e-06	9.89e-05	CbGpPWpGaD
